Skip to main content
Contact Us
Subscribe
e-Edition
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
Facebook
Site search
Search
Menu
Subscribe
Home
Contact Us
Terms of Use
Privacy Policy
Home Delivery
Subscribe
Submission Forms
Place an Ad
Weather
News
Sports
Entertainment
Calendar
Obituaries
Classifieds
Place an ad
e-Edition
Best of 2023
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Eledon Pharmaceuticals Inc
(NQ:
ELDN
)
4.660
-0.170 (-3.52%)
Streaming Delayed Price
Updated: 4:00 PM EST, Dec 11, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Eledon Pharmaceuticals Inc
< Previous
1
2
3
Next >
12 Health Care Stocks Moving In Wednesday's After-Market Session
October 30, 2024
Via
Benzinga
ELDN Stock Earnings: Eledon Pharma Misses EPS for Q2 2024
August 19, 2024
ELDN stock results show that Eledon Pharma missed analyst estimates for earnings per share the second quarter of 2024.
Via
InvestorPlace
Penny Stock Picks: 3 Companies Poised to Graduate to the Big Leagues
June 17, 2024
You don’t want to overlook these three penny stocks filled to the brim with the potential to make huge leaps in their respective markets.
Via
InvestorPlace
3 High-Potential Penny Stocks to Turn $1000 into $1 Million: June 2024
June 11, 2024
Although the very idea of millionaire-maker penny stocks implies incredibly high risks, if all cylinders fire, these companies could fly.
Via
InvestorPlace
12 Health Care Stocks Moving In Friday's After-Market Session
May 17, 2024
Via
Benzinga
Expert Ratings for Eledon Pharma
November 13, 2023
Via
Benzinga
Recap: Eledon Pharma Q1 Earnings
May 11, 2023
Via
Benzinga
Eledon Pharma's Earnings: A Preview
May 10, 2023
Via
Benzinga
Eledon Pharmaceuticals's Earnings: A Preview
March 29, 2023
Via
Benzinga
ELDN Stock Earnings: Eledon Pharma Beats EPS for Q1 2024
May 09, 2024
ELDN stock results show that Eledon Pharma beat analyst estimates for earnings per share the first quarter of 2024.
Via
InvestorPlace
Nano-Cap Eledon Pharmaceuticals' Investigational Drug Shows Safety In Early Organ Transplant Study, Analyst Boosts Forecast On Increased Confidence
May 07, 2024
Eledon Pharmaceuticals' results from islet cell transplant trial for type 1 diabetes, with tegoprubart showing safety and efficacy in kidney transplant patients. Analysts anticipate significant...
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
May 07, 2024
Via
Benzinga
ELDN Stock Earnings: Eledon Pharma Beats EPS for Q4 2023
March 28, 2024
ELDN stock results show that Eledon Pharma beat analyst estimates for earnings per share the fourth quarter of 2023.
Via
InvestorPlace
Kidney Transplant From Genetically Edited Pig: Boston Patient With End-Stage Renal Disease Becomes First To Receive
March 21, 2024
Eledon Pharmaceuticals announces successful use of tegoprubart in kidney xenotransplant. Promising results show its potential to prevent rejection, marking a significant milestone in organ...
Via
Benzinga
Eledon Pharma: Q2 Earnings Insights
August 11, 2022
Eledon Pharma (NASDAQ:ELDN) reported its Q2 earnings results on Thursday, August 11, 2022 at 04:01 PM. Here's what investors need to know about the announcement.
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For September 27, 2023
September 27, 2023
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
September 27, 2023
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
August 02, 2023
Via
Benzinga
Stocks That Hit 52-Week Lows On Tuesday
July 25, 2023
On Tuesday, 56 companies set new 52-week lows.
Via
Benzinga
Stocks That Hit 52-Week Lows On Thursday
June 15, 2023
On Thursday, 64 companies achieved new lows for the year.
Via
Benzinga
Why Chewy Shares Are Trading Higher By 17%; Here Are 20 Stocks Moving Premarket
June 01, 2023
Gainers Airspan Networks Holdings Inc. (NYSE: MIMO) shares rose 58.9% to $0.3754 in pre-market trading. Airspan Networks recently reported new financing and leadership changes.
Via
Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday
June 01, 2023
It's time to start the day with a breakdown of the biggest pre-market stock movers that traders need to know about for Thursday morning!
Via
InvestorPlace
12 Health Care Stocks Moving In Thursday's Intraday Session
April 13, 2023
Via
Benzinga
12 Health Care Stocks Moving In Thursday's Pre-Market Session
March 30, 2023
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's After-Market Session
December 21, 2022
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's After-Market Session
September 06, 2022
Gainers Metacrine (NASDAQ:MTCR) shares rose 13.8% to $0.54 during Tuesday's after-market session. This security traded at a volume of 3.0 million shares come close, making up 948.6% of its average...
Via
Benzinga
Eledon Shares Climb After Securing FDA Nod For Mid-Stage Kidney Disease Study
September 06, 2022
Eledon Pharmaceuticals (NASDAQ: ELDN) received clearance from the U.S. Food and Drug Administration (FDA) for its Investigational New Drug (IND) application to evaluate tegoprubart for the treatment of...
Via
Benzinga
Eledon Pharmaceuticals Earnings: A Preview
August 10, 2022
Eledon Pharmaceuticals (NASDAQ:ELDN) is set to give its latest quarterly earnings report on Thursday, 2022-08-11. Here's what investors need to know before the announcement.
Via
Benzinga
Recap Of Monday's Biotech Catalysts - End Of the Day Summary
August 01, 2022
Via
Benzinga
Daily Biotech Pulse: Celyad Resumes Colorectal Cancer Trial, Setback For Otonomy, AstraZeneca Halts Phase 3 Head, Neck Cancer Trial
August 01, 2022
Here's a roundup of top developments in the biotech space over the last 24 hours:
Via
Benzinga
< Previous
1
2
3
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.